How have CELZ shares performed in 2024?

Creative Medical Technology's stock was trading at $4.61 at the start of the year. Since then, CELZ shares have increased by 4.3% and is now trading at $4.81. View the best growth stocks for 2024 here .

Are investors shorting Creative Medical Technology?

Creative Medical Technology saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 28,700 shares, a drop of 30.8% from the March 15th total of 41,500 shares. Based on an average daily trading volume, of 200,700 shares, the short-interest ratio is presently 0.1 days. Currently, 2.2% of the company's stock are short sold. View Creative Medical Technology's Short Interest .

When is Creative Medical Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024. View our CELZ earnings forecast .

How were Creative Medical Technology's earnings last quarter?

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its earnings results on Friday, March, 22nd. The company reported ($1.21) EPS for the quarter, missing the consensus estimate of ($1.13) by $0.08.

When did Creative Medical Technology's stock split?

Creative Medical Technology's stock reverse split before market open on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Creative Medical Technology?

Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CELZ

Creative Medical Technology (CELZ) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free CELZ Stock Alerts

$4.81

-0.19 (-3.80%)

(As of 04/18/2024 ET)

Compare

Today's Range: $4.81
▼
$4.98
50-Day Range: $4.03
▼
$6.45
52-Week Range: $3.93
▼
$10.28

Volume: 14,498 shs
Average Volume: 174,719 shs
Market Capitalization: $6.54 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Creative Medical Technology alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Creative Medical Technology Stock (NASDAQ:CELZ)

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

CELZ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CELZ Stock News Headlines

March 24, 2024 | finance.yahoo.com

Creative Medical Technology Holdings Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags

March 18, 2024 | forbes.com

Medical Practices And Branding In A Digital Age

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 18, 2024 | theglobeandmail.com

Creative Medical Technology Skyrockets on Word of New Diabetes Medication

March 7, 2024 | msn.com

Why Is Diabetes Focused Creative Medical Stock Surging On Thursday?

March 7, 2024 | markets.businessinsider.com

Creative Medical Announces FDA Authorization For Expanded Access For CELZ-201; Stock Up

March 7, 2024 | marketwatch.com

Creative Medical Shares Rise 37% After FDA Authorization for CELZ-201

March 7, 2024 | msn.com

Creative Medical stock rallies for second day on FDA updates

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 7, 2024 | finance.yahoo.com

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access

March 6, 2024 | morningstar.com

Creative Medical Technology Holdings Inc

March 6, 2024 | markets.businessinsider.com

Creative Medical Receives FDA Orphan Drug Designation For CELZ-101; Stock Up In Pre-market

March 6, 2024 | marketwatch.com

Creative Medical Shares Rally Premarket on FDA Orphan Designation

March 6, 2024 | msn.com

Creative Medical stock rallies 18% on FDA orphan drug designation

March 6, 2024 | businesswire.com

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy

February 15, 2024 | investing.com

Creative Medical Technology Holdings Inc (CELZ)

February 9, 2024 | benzinga.com

Steven L White's Net Worth

December 20, 2023 | finance.yahoo.com

Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain

October 11, 2023 | msn.com

Creative Medical to initiate trial of lower back pain treatment

October 10, 2023 | markets.businessinsider.com

Creative Medical Gets IRB Approval For StemSpine Trial Using AlloStem Cell Therapy

October 10, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain

September 22, 2023 | finance.yahoo.com

What Makes Creative Medical Technology Holdings, Inc. (CELZ) a New Buy Stock

September 19, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain

August 24, 2023 | finance.yahoo.com

What Is Allogeneic Cell Therapy, And What’s Driving This Market’s 25%+ Annual Global Growth?

August 23, 2023 | benzinga.com

What Is Allogeneic Cell Therapy, And What's Driving This Market's 25%+ Annual Global Growth?

June 28, 2023 | msn.com

Creative Medical Technology regains Nasdaq listing compliance

June 12, 2023 | finance.yahoo.com

Creative Medical Technology Holdings Provides Corporate Update

See More Headlines

Receive CELZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creative Medical Technology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/22/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/10/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Current Symbol: NASDAQ:CELZ
CUSIP: N/A
CIK: 1187953
Web: www.creativemedicaltechnology.com
Phone: (833) 336-7636
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($3.71)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-5,290,000.00
Net Margins: N/A
Pretax Margin: -58,744.45%
Return on Equity: -41.48%
Return on Assets: -40.22%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 27.68
Quick Ratio: 27.67

Sales & Book Value

Annual Sales: $10,000.00
Price / Sales: 654.16
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $7.48 per share
Price / Book: 0.64

Miscellaneous

Outstanding Shares: 1,360,000
Free Float: 1,312,000
Market Cap: $6.54 million
Optionable: Not Optionable
Beta: 2.21

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Timothy Warbington (Age 62)
Co-Founder, Chairman, President & CEO
Comp: $429k
Mr. Donald Dickerson (Age 59)
Senior VP, CFO & Director
Comp: $390k

Key Competitors

View All Competitors

Insiders

Timothy Warbington
Bought 800 shares on 6/27/2023
Total: $3,552.00 ($4.44/share)

View All Insider Transactions

CELZ Stock Analysis - Frequently Asked Questions

How have CELZ shares performed in 2024?: Creative Medical Technology's stock was trading at $4.61 at the start of the year. Since then, CELZ shares have increased by 4.3% and is now trading at $4.81.
View the best growth stocks for 2024 here.
Are investors shorting Creative Medical Technology?: Creative Medical Technology saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 28,700 shares, a drop of 30.8% from the March 15th total of 41,500 shares. Based on an average daily trading volume, of 200,700 shares, the short-interest ratio is presently 0.1 days. Currently, 2.2% of the company's stock are short sold.
View Creative Medical Technology's Short Interest.
When is Creative Medical Technology's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, May 10th 2024.
View our CELZ earnings forecast.
How were Creative Medical Technology's earnings last quarter?: Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) issued its earnings results on Friday, March, 22nd. The company reported ($1.21) EPS for the quarter, missing the consensus estimate of ($1.13) by $0.08.

When did Creative Medical Technology's stock split?: Creative Medical Technology's stock reverse split before market open on Sunday, June 11th 2023. The 1-10 reverse split was announced on Sunday, June 11th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, June 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
How do I buy shares of Creative Medical Technology?: Shares of CELZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CELZ) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Creative Medical Technology (CELZ) Stock Price, News & Analysis

About Creative Medical Technology Stock (NASDAQ:CELZ)

CELZ Stock Price History

CELZ Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

CELZ Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info